Alternative splicing (AS) is the process of combinatorial rearrangement of parts of exons, and/or parts of introns into mature RNA to result in a multitude of transcripts. AS is a biological process through which organisms produce as many protein variants as possible by a limited genetic resource. It plays an important role in growth and development of the organisms. Over the past few years, alternative splicing has been discovered to be critical for genesis and development of malignant tumors, including breast cancer. If the relationships between AS and breast cancer can be discussed more deeply, it will be helpful for better diagnosis, judging prognosis and intervening with breast cancer. In this paper, the relationships between AS and breast cancer are elaborated from different angles, in hope that this summary is beneficial for readers to understand the roles of AS and breast cancer.
A summary of relationships between alternative splicing and breast cancer
Z. Xiping,Wei Qing-shan,Zhao Shuai,Yang Hongjian,Ding Xiaowen
Published 2017 in OncoTarget
ABSTRACT
PUBLICATION RECORD
- Publication year
2017
- Venue
OncoTarget
- Publication date
2017-05-09
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-67 of 67 references · Page 1 of 1
CITED BY
Showing 1-8 of 8 citing papers · Page 1 of 1